0 followers
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Kleanthis G. Xanthopoulos
Immunome
2 followers
Amgen
200 followers
Elicio Therapeutics
1 follower
Artiva Biotherapeutics
1 follower
Miami Foundation
2 followers
Cytokinetics
11 followers
Capricor Therapeutics
1 follower
Politecnico di Milano
5 followers
Azim Premji University
4 followers
4D Molecular Therapeutics
3 followers
The Cumulus Coffee Company
2 followers
Explore companies